BiotechTube

Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Presbyopia

Conditions

Presbyopia, Near Vision, Refractive Error, Eye Diseases

Trial Timeline

Mar 6, 2023 → Jan 24, 2024

NCT ID
NCT05728944

About Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle

Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle is a phase 3 stage product being developed by LENZ Therapeutics for Presbyopia. The current trial status is completed. This product is registered under clinical trial identifier NCT05728944. Target conditions include Presbyopia, Near Vision, Refractive Error.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT05728944Phase 3Completed

Competing Products

14 competing products in Presbyopia

See all competitors
ProductCompanyStageHype Score
AGN-241622 + VehicleAbbViePhase 1/2
41
AGN-190584AbbVieApproved
85
AGN-190584 + VehicleAbbViePhase 3
77
UNR844 + PlaceboNovartisPhase 2
52
UNR844-Cl + PlaceboNovartisPhase 2
52
Pilocarpine Ophthalmic Topical Cream, Dose 1 + Pilocarpine Ophthalmic Topical Cream, Dose 2 + Pilocarpine Ophthalmic Topical Cream, Dose 3 + Placebo Ophthalmic Topical CreamGlaukosPhase 2
49
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle Proprietary Ophthalmic SolutionLENZ TherapeuticsPhase 2
44
Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionLENZ TherapeuticsPhase 3
69
PRX-100 + PlaceboLENZ TherapeuticsPhase 2
44
Aceclidine+tropicamide combination + Aceclidine + VehicleLENZ TherapeuticsPhase 2
44
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution + LNZ100 (Aceclidine) ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 1
25
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle proprietary ophthalmic solutionLENZ TherapeuticsPhase 2
44
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + BrimonidineLENZ TherapeuticsPhase 3
69

Other Products from LENZ Therapeutics

Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionPhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + BrimonidinePhase 3
69
Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Vehicle Proprietary Ophthalmic SolutionPhase 2
44
PRX-100 + PlaceboPhase 2
44